Literature DB >> 24231588

Bacillus Calmette-Guérin is a preventive factor in mortality of childhood tuberculous meningitis.

Selvi Kelekçi1, Müsemma Karabel2, Duran Karabel2, Cihat Hamidi3, Salih Hoşoğlu4, M Fuat Gürkan2, M Ali Taş2.   

Abstract

OBJECTIVES: Studies have been done that have focused on the efficacy of bacillus Calmette-Guérin (BCG) vaccination in the prevention of cases of childhood tuberculous meningitis (TBM). However the efficacy of the vaccination in the prevention of mortality has not been sufficiently evaluated. This study aimed to determine the main features of TBM cases in childhood and to evaluate the factors related to mortality, proving the protective effect of BCG vaccination in childhood TBM.
METHODS: In a retrospective approach, all consecutive cases of TBM in children that occurred between 1997 and 2005, at Dicle University Hospital, were studied. The following data were evaluated: demographic aspects, admission symptoms, radiology and laboratory findings, BCG vaccination status, tuberculin skin test (TST) positivity, and mortality rates.
RESULTS: In total, 172 cases of childhood TBM were evaluated (mean age 53.3±55.7 months; 109 boys (63.4%)). The majority of these cases (70.4%) had typical TBM symptoms on admission. BCG vaccination data were available for 152 (88.4%) cases and 29 of them (19.1%) were positive. The TST was performed for 143 patients (83.1%) and 28 (19.6%) were found positive. Hydrocephalus was identified in 118 patients (68.6%) on computed tomography examination. A shunt was placed in 79 cases (45.9%). In total, 24 patients (14.0%) died in the hospital. TST negativity was a significant factor for mortality (p=0.012). BCG positivity was found to be a preventive factor from mortality (p=0.05).
CONCLUSIONS: BCG vaccination is effective in the prevention of TBM-associated mortality in childhood. TST negativity may be a sign of a poor prognosis in TBM cases.
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  BCG; Mortality; TST; Tuberculous meningitis

Mesh:

Substances:

Year:  2013        PMID: 24231588     DOI: 10.1016/j.ijid.2013.10.001

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

Review 1.  Recommendations for pediatric tuberculosis vaccination in Italy.

Authors:  Carlotta Montagnani; Susanna Esposito; Luisa Galli; Elena Chiappini; Nicola Principi; Maurizio de Martino
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Potential of Host Serum Protein Biomarkers in the Diagnosis of Tuberculous Meningitis in Children.

Authors:  Charles M Manyelo; Regan S Solomons; Candice I Snyders; Hygon Mutavhatsindi; Portia M Manngo; Kim Stanley; Gerhard Walzl; Novel N Chegou
Journal:  Front Pediatr       Date:  2019-09-25       Impact factor: 3.418

3.  BCG scar, socioeconomic and nutritional status: a study of newborns in urban area of Makassar, Indonesia.

Authors:  Aldian Irma Amaruddin; Sitti Wahyuni; Firdaus Hamid; Maisuri T Chalid; Maria Yazdanbakhsh; Erliyani Sartono
Journal:  Trop Med Int Health       Date:  2019-04-05       Impact factor: 2.622

4.  Tubercular meningitis in children: Clinical, pathological, and radiological profile and factors associated with mortality.

Authors:  Anil V Israni; Divya A Dave; Anirban Mandal; Amitabh Singh; Puneet K Sahi; Rashmi Ranjan Das; Arpita Shah
Journal:  J Neurosci Rural Pract       Date:  2016 Jul-Sep

Review 5.  Tuberculous meningitis in children: Clinical management & outcome.

Authors:  Bella Devaleenal Daniel; G Angeline Grace; Mohan Natrajan
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

Review 6.  The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes.

Authors:  James A Seddon; Lillian Tugume; Regan Solomons; Kameshwar Prasad; Nathan C Bahr
Journal:  Wellcome Open Res       Date:  2019-11-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.